Bayer AG BAYN

Morningstar Rating
€30.40 −0.05 (0.16%)
View Full Chart

Company Report

Price vs Fair Value

BAYN is trading at a 668% premium.
Price
€30.39
Fair Value
€93.00
Uncertainty
High
1-Star Price
€915.70
5-Star Price
€76.50
Economic Moat
Lhsljnx
Capital Allocation
Hrs

Bulls Say, Bears Say

Bulls

Several drugs, including recently launched cancer drugs, hold potential for further gains and have relatively steady pricing power partly based on excellent clinical data.

Bears

Biosimilar pressures to long-acting Eylea could emerge more quickly than expected if patents on the new version of the drug lack differentiation versus the short-acting version.

News

Trading Information

Previous Close Price
€30.45
Day Range
€30.1330.71
52-Week Range
€24.9645.46
Bid/Ask
€0.00 / €30.36
Market Cap
€29.86 Bil
Volume/Avg
1.7 Mil / 3.0 Mil

Key Statistics

Price/Earnings (Normalized)
5.62
Price/Sales
0.63
Dividend Yield (Trailing)
0.36%
Dividend Yield (Forward)
0.36%
Total Yield
0.36%

Company Profile

Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Large Value
Total Number of Employees
96,567

Competitors

Valuation

Metric
BAYN
PFE
BMY
Price/Earnings (Normalized)
5.6220.997.02
Price/Book Value
0.841.856.40
Price/Sales
0.632.912.35
Price/Cash Flow
4.4421.207.21
Price/Earnings
BAYN
PFE
BMY

Financial Strength

Metric
BAYN
PFE
BMY
Quick Ratio
0.860.510.94
Current Ratio
1.270.861.16
Interest Coverage
0.70−0.88−3.16
Quick Ratio
BAYN
PFE
BMY

Profitability

Metric
BAYN
PFE
BMY
Return on Assets (Normalized)
4.94%3.50%3.04%
Return on Equity (Normalized)
16.84%8.28%11.63%
Return on Invested Capital (Normalized)
9.08%5.39%5.77%
Return on Assets
BAYN
PFE
BMY

Drug Manufacturers - General Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Eli Lilly and Co
LLY
HwflbgwgDgl$802.3 Bil
Johnson & Johnson
JNJ
YqzvyznrJtlf$388.0 Bil
AbbVie Inc
ABBV
ZcyscypbjFsr$347.7 Bil
Merck & Co Inc
MRK
KxlbdpwsGfpm$284.1 Bil
Roche Holding AG ADR
RHHBY
QrlgknlrrtFwnf$252.2 Bil
AstraZeneca PLC ADR
AZN
HfmwhrymhvJcm$245.8 Bil
Novartis AG ADR
NVS
RrqrfhhdSds$232.6 Bil
Amgen Inc
AMGN
DgbwrkgydMpjj$171.8 Bil
Pfizer Inc
PFE
ClznxfntSdqwz$162.1 Bil
Sanofi SA ADR
SNY
RfhgxrcmgGjtb$141.7 Bil

Sponsor Center